Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2

We evaluated the performance of the BioFire® Respiratory Panel 2.1 (RP2.1) in the detection of SARS CoV-2 in comparison against three other SARS CoV-2 EUA assays. In these studies, the RP2.1 panel had 98 % positive percent agreement (48/49) and 100 % negative percent agreement (49/49). Since 30 % of...

Descripción completa

Detalles Bibliográficos
Autores principales: Creager, Hannah M., Cabrera, Barbara, Schnaubelt, Andy, Cox, Jesse L., Cushman-Vokoun, Allison M., Shakir, Salika M., Tardif, Keith D., Huang, Meei-Li, Jerome, Keith R., Greninger, Alexander L., Drobysheva, Daria, Spaulding, Usha, Rogatcheva, Margarita, Bourzac, Kevin M., Hinrichs, S.H., Broadhurst, M.J., Fey, P.D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336953/
https://www.ncbi.nlm.nih.gov/pubmed/32650276
http://dx.doi.org/10.1016/j.jcv.2020.104538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336953/
https://www.ncbi.nlm.nih.gov/pubmed/32650276
http://dx.doi.org/10.1016/j.jcv.2020.104538

Ejemplares similares